Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Supernus: Q4 Earnings Snapshot AP - Tue Feb 27, 5:02PM CST

Supernus: Q4 Earnings Snapshot

SUPN : 30.25 (+3.95%)
Supernus: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Supernus: Q3 Earnings Snapshot

SUPN : 30.25 (+3.95%)
Supernus: Q2 Earnings Snapshot AP - Tue Aug 8, 2023

Supernus: Q2 Earnings Snapshot

SUPN : 30.25 (+3.95%)
Despite 1 Major Headwind and Pricey Shares, This Stock Is Still a Buy Motley Fool - Sat Jun 10, 2023

Supernus Pharmaceuticals' revenue mix is shifting, and it could soon have more sales on the way.

SUPN : 30.25 (+3.95%)
Supernus: Q1 Earnings Snapshot AP - Tue May 9, 2023

Supernus: Q1 Earnings Snapshot

SUPN : 30.25 (+3.95%)
Supernus: Q4 Earnings Snapshot AP - Tue Feb 28, 2023

Supernus: Q4 Earnings Snapshot

SUPN : 30.25 (+3.95%)
Supernus: Q3 Earnings Snapshot AP - Tue Nov 8, 2022

Supernus: Q3 Earnings Snapshot

SUPN : 30.25 (+3.95%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire - Thu Nov 3, 2022

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. (""Supernus" or the "Company") (NASDAQ: SUPN)....

SUPN : 30.25 (+3.95%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire - Wed Oct 26, 2022

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. (""Supernus" or the "Company") (NASDAQ: SUPN)....

SUPN : 30.25 (+3.95%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN PR Newswire - Tue Oct 18, 2022

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN)....

SUPN : 30.25 (+3.95%)

Barchart Exclusives

Grains: Watson and Occam’s Razor Barchart - 7 minutes ago
Occam's razor tells us the simplest answer is usually closest to the truth. We need to keep this in mind as we look at the early rally in the Grains sector Monday morning. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot